Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for prevention of contrast-induced nephropathy in ACS (PRATO-ACS)
NCT01185938Phase 4Completed
- Sponsor
- Centro Cardiopatici Toscani
- Start
- Jul 2010
- Primary completion
- Sep 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in contrast-induced nephropathy (CIN), myocardial infarction (MI), sponsored by Centro Cardiopatici Toscani. Started Jul 2010; status: completed.
02
Drugs
rosuvastatin
03
Conditions
contrast-induced nephropathy (CIN)myocardial infarction (MI)
Beyond the preview
Go deeper on NCT01185938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01185938.